In silico pharmacology for drug discovery: applications to targets and beyond
Open Access
- 1 September 2007
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 152 (1), 21-37
- https://doi.org/10.1038/sj.bjp.0707306
Abstract
Computational (in silico) methods have been developed and widely applied to pharmacology hypothesis development and testing. These in silico methods include databases, quantitative structure-activity relationships, similarity searching, pharmacophores, homology models and other molecular modeling, machine learning, data mining, network analysis tools and data analysis tools that use a computer. Such methods have seen frequent use in the discovery and optimization of novel molecules with affinity to a target, the clarification of absorption, distribution, metabolism, excretion and toxicity properties as well as physicochemical characterization. The first part of this review discussed the methods that have been used for virtual ligand and target-based screening and profiling to predict biological activity. The aim of this second part of the review is to illustrate some of the varied applications of in silico methods for pharmacology in terms of the targets addressed. We will also discuss some of the advantages and disadvantages of in silico methods with respect to in vitro and in vivo methods for pharmacology research. Our conclusion is that the in silico pharmacology paradigm is ongoing and presents a rich array of opportunities that will assist in expediating the discovery of new targets, and ultimately lead to compounds with predicted biological activity for these novel targets.Keywords
This publication has 143 references indexed in Scilit:
- Pharmacophore-based discovery of ligands for drug transportersAdvanced Drug Delivery Reviews, 2006
- QSAR Modeling of in Vitro Inhibition of Cytochrome P450 3A4*Journal of Chemical Information and Modeling, 2006
- A Preliminary in Silico Lead Series of 2-Phthalimidinoglutaric Acid Analogues Designed as MMP-3 InhibitorsJournal of Chemical Information and Modeling, 2006
- In silico search of putative adverse drug reaction related proteins as a potential tool for facilitating drug adverse effect predictionToxicology Letters, 2006
- Multiple-Ligand-Based Virtual Screening: Methods and Applications of the MTree ApproachJournal of Medicinal Chemistry, 2005
- Pharmacophore Modeling, Docking, and Principal Component Analysis Based Clustering: Combined Computer-Assisted Approaches To Identify New Inhibitors of the Human Rhinovirus Coat ProteinJournal of Medicinal Chemistry, 2005
- Human Rhinovirus 3C Protease: Generation of Pharmacophore Models for Peptidic and Nonpeptidic Inhibitors and Their Application in Virtual ScreeningJournal of Chemical Information and Modeling, 2005
- QUANTITATIVE STRUCTURE-METABOLISM RELATIONSHIP MODELING OF METABOLICN-DEALKYLATION REACTION RATESDrug Metabolism and Disposition, 2004
- Crystal Structure of a UBP-Family Deubiquitinating Enzyme in Isolation and in Complex with Ubiquitin AldehydeCell, 2002
- Identification of Potent and Novel α4β1 Antagonists Using in Silico ScreeningJournal of Medicinal Chemistry, 2002